We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Researchers found that they could design nanomaterials that mimic dead and dying red blood cells, causing them to be retained in the spleen and enabling them to deliver inhibitors that modulate the inflammatory response.